MedTrace Logo

Basal Bolus Versus Human Insulin in Hospitalized Patients With Diabetes in Paraguay

NCT02278913 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 134

Last updated 2014-10-30

No results posted yet for this study

Summary

Few randomized studies have focused on the optimal management of non-ICU patients with type 2 diabetes in Latin America. Objective: Compare safety and efficacy of a basal bolus regimen with analogs and human insulins in general medicine patients admitted to a University Hospital in Asuncion, Paraguay.

Conditions

Interventions

DRUG

Basal Bolus (Glargine and Glulisine)

Glargine daily + Glulisine before meals

DRUG

Human Insulin

NPH twice a day + Regular insulin before meals

Sponsors & Collaborators

  • Universidad Nacional de Asunción

    lead OTHER

Principal Investigators

  • Elvio Bueno, MD · Universida Nacional de Asuncion

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2010-04-30
Completion
2011-03-31

Countries

  • Paraguay

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02278913 on ClinicalTrials.gov